{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:30:44Z","timestamp":1790775044398,"version":"4.1.0"},"reference-count":50,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2018,11,29]]},"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Non-invasive and accurate diagnostic tests for the screening of disease severity in non-alcoholic fatty liver disease (NAFLD) remain a major unmet need. Therefore, we aimed to examine if a combination of serum metabolites can accurately predict the presence of advanced fibrosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>This is a cross-sectional analysis of a prospective <jats:italic>derivation<\/jats:italic> cohort including 156 well-characterised patients with biopsy-proven NAFLD and two <jats:italic>validation<\/jats:italic> cohorts, including (1) 142 patients assessed using MRI elastography (MRE) and(2) 59 patients with biopsy-proven NAFLD with untargeted serum metabolome profiling.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the <jats:italic>derivation<\/jats:italic> cohort, 23 participants (15%) had advanced fibrosis and 32 of 652 analysed metabolites were significantly associated with advanced fibrosis after false-discovery rate adjustment. Among the top 10 metabolites, 8 lipids (5alpha-androstan-3beta monosulfate, pregnanediol-3-glucuronide, androsterone sulfate, epiandrosterone sulfate, palmitoleate, dehydroisoandrosterone sulfate, 5alpha-androstan-3beta disulfate, glycocholate), one amino acid (taurine) and one carbohydrate (fucose) were identified. The combined area under the receiver operating characteristic curve (AUROC) of the top 10 metabolite panel was higher than FIB--4 and NAFLD Fibrosis Score (NFS) for the detection of advanced fibrosis: 0.94 (95% CI 0.897 to 0.982) versus 0.78 (95% CI0.674 to 0.891), p=0.002\u2009and versus 0.84 (95% CI 0.724 to 0.929), p=0.017, respectively. The AUROC of the top 10 metabolite panel remained excellent in the independent validation cohorts assessed by MRE or liver biopsy: c-statistic of 0.94 and 0.84, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>A combination of 10 serum metabolites demonstrated excellent discriminatory ability for the detection of advanced fibrosis in an <jats:italic>derivation<\/jats:italic> and two independent <jats:italic>validation<\/jats:italic> cohorts with greater diagnostic accuracy than the FIB-4-index and NFS. This proof-of-concept study demonstrates that a non-invasive blood-based diagnostic test can provide excellent performance characteristics for the detection of advanced fibrosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/gutjnl-2018-317584","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T17:15:40Z","timestamp":1545239740000},"page":"1884-1892","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":79,"title":["Serum metabolites detect the presence of advanced fibrosis in derivation and validation cohorts of patients with non-alcoholic fatty liver disease"],"prefix":"10.1136","volume":"68","clinical-trial-number":[{"clinical-trial-number":"nct01643512","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Cyrielle","family":"Caussy","sequence":"first","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, La Jolla, California, USA"},{"name":"Universit\u00e9 Lyon 1, Hospices Civils de Lyon, Lyon, California, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veeral H","family":"Ajmera","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Puri","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University, Richmond, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2604-1340","authenticated-orcid":false,"given":"Cynthia Li-Shin","family":"Hsu","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Bassirian","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mania","family":"Mgdsyan","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Singh","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Faulkner","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Valasek","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California at San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Rizo","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Richards","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Brenner","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, La Jolla, California, USA"},{"name":"Division of Gastroenterology, Department of Medicine, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude B","family":"Sirlin","sequence":"additional","affiliation":[{"name":"Liver Imaging Group, Department of Radiology, University of California, San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun J","family":"Sanyal","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University, Richmond, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Loomba","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, La Jolla, California, USA"},{"name":"Division of Gastroenterology, Department of Medicine, La Jolla, California, USA"},{"name":"Division of Epidemiology, Department of Family and Preventive Medicine, University of California at San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,12,19]]},"reference":[{"key":"2025090711530252000_68.10.1884.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.171"},{"key":"2025090711530252000_68.10.1884.2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431"},{"key":"2025090711530252000_68.10.1884.3","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"2025090711530252000_68.10.1884.4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.043"},{"key":"2025090711530252000_68.10.1884.5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27368"},{"key":"2025090711530252000_68.10.1884.6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jhep.2017.11.028","article-title":"Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions","volume":"68","author":"Loomba","year":"2018","journal-title":"J Hepatol"},{"key":"2025090711530252000_68.10.1884.7","unstructured":"Younossi ZM , Loomba R , Anstee QM , et al . Diagnostic Modalities for Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) and Associated Fibrosis. Hepatology 2017."},{"key":"2025090711530252000_68.10.1884.8","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.216077"},{"key":"2025090711530252000_68.10.1884.9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","article-title":"Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers","volume":"68","author":"Vilar-Gomez","year":"2018","journal-title":"J Hepatol"},{"key":"2025090711530252000_68.10.1884.10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23229"},{"key":"2025090711530252000_68.10.1884.11","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/j.gastro.2017.01.015","article-title":"Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis","volume":"152","author":"Alonso","year":"2017","journal-title":"Gastroenterology"},{"key":"2025090711530252000_68.10.1884.12","doi-asserted-by":"publisher","DOI":"10.1021\/pr201223p"},{"key":"2025090711530252000_68.10.1884.13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4083"},{"key":"2025090711530252000_68.10.1884.14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/hep.28899","article-title":"Metabolic profiling of fatty liver in young and middle-aged adults: Cross-sectional and prospective analyses of the Young Finns Study","volume":"65","author":"Kaikkonen","year":"2017","journal-title":"Hepatology"},{"key":"2025090711530252000_68.10.1884.15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/liv.13249","article-title":"Nonalcoholic steatohepatitis is associated with a state of betaine-insufficiency","volume":"37","author":"Sookoian","year":"2017","journal-title":"Liver Int"},{"key":"2025090711530252000_68.10.1884.16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/hep.22063","article-title":"Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease","volume":"47","author":"Charlton","year":"2008","journal-title":"Hepatology"},{"key":"2025090711530252000_68.10.1884.17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jpeds.2016.01.026","article-title":"Amino acid metabolism is altered in adolescents with nonalcoholic fatty liver disease-an untargeted, high resolution metabolomics study","volume":"172","author":"Jin","year":"2016","journal-title":"J Pediatr"},{"key":"2025090711530252000_68.10.1884.18","doi-asserted-by":"crossref","unstructured":"Puri P , Daita K , Joyce A , et al . The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids. Hepatology 2017.doi:10.1002\/hep.29359","DOI":"10.1002\/hep.29359"},{"key":"2025090711530252000_68.10.1884.19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF03401306","article-title":"Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease","volume":"12","author":"Polyzos","year":"2013","journal-title":"Hormones"},{"key":"2025090711530252000_68.10.1884.20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1478-3231.2011.02637.x","article-title":"Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients","volume":"32","author":"Koehler","year":"2012","journal-title":"Liver Int"},{"key":"2025090711530252000_68.10.1884.21","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.P055640"},{"key":"2025090711530252000_68.10.1884.22","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","article-title":"Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"152","author":"Park","year":"2017","journal-title":"Gastroenterology"},{"key":"2025090711530252000_68.10.1884.23","doi-asserted-by":"crossref","unstructured":"Caussy C , Hsu C , Lo MT , et al . Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD. Hepatology 2018:918\u201332.doi:10.1002\/hep.29892","DOI":"10.1002\/hep.29892"},{"key":"2025090711530252000_68.10.1884.24","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.cgh.2017.10.037","article-title":"Association between obesity and discordance in fibrosis stage determination by magnetic resonance vs transient elastography in patients with nonalcoholic liver disease","volume":"16","author":"Caussy","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090711530252000_68.10.1884.25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.gastro.2018.04.014","article-title":"Magnetic resonance imaging proton density fat fraction associates with progression of fibrosis in patients with nonalcoholic fatty liver disease","volume":"155","author":"Ajmera","year":"2018","journal-title":"Gastroenterology"},{"key":"2025090711530252000_68.10.1884.26","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309456"},{"key":"2025090711530252000_68.10.1884.27","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.08.011"},{"key":"2025090711530252000_68.10.1884.28","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.28674","article-title":"Shared genetic effects between hepatic steatosis and fibrosis: a prospective twin study","volume":"64","author":"Cui","year":"2016","journal-title":"Hepatology"},{"key":"2025090711530252000_68.10.1884.29","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1172\/JCI93465","article-title":"Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis","volume":"127","author":"Caussy","year":"2017","journal-title":"J Clin Invest"},{"key":"2025090711530252000_68.10.1884.30","doi-asserted-by":"publisher","DOI":"10.1021\/ac901536h"},{"key":"2025090711530252000_68.10.1884.31","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2946-2-9"},{"key":"2025090711530252000_68.10.1884.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05121.x"},{"key":"2025090711530252000_68.10.1884.33","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12237"},{"key":"2025090711530252000_68.10.1884.34","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20701"},{"key":"2025090711530252000_68.10.1884.35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178"},{"key":"2025090711530252000_68.10.1884.36","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21496"},{"key":"2025090711530252000_68.10.1884.37","doi-asserted-by":"publisher","DOI":"10.2307\/2531595"},{"key":"2025090711530252000_68.10.1884.38","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/hepr.12647","article-title":"Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: A meta-analysis study","volume":"46","author":"Sun","year":"2016","journal-title":"Hepatol Res"},{"key":"2025090711530252000_68.10.1884.39","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"2025090711530252000_68.10.1884.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.05.046"},{"key":"2025090711530252000_68.10.1884.41","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Ch\u00e1vez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"2025090711530252000_68.10.1884.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2010.03.006"},{"key":"2025090711530252000_68.10.1884.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2007.03.022"},{"key":"2025090711530252000_68.10.1884.44","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-0-387-75681-3_30","article-title":"The protective effect of taurine against hepatic damage in a model of liver disease and hepatic stellate cells","volume":"643","author":"Miyazaki","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"2025090711530252000_68.10.1884.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2008.09.017"},{"key":"2025090711530252000_68.10.1884.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.hepres.2003.11.012"},{"key":"2025090711530252000_68.10.1884.47","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28002"},{"key":"2025090711530252000_68.10.1884.48","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27362"},{"key":"2025090711530252000_68.10.1884.49","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jhep.2013.12.009","article-title":"A population-based study on the prevalence of NASH using scores validated against liver histology","volume":"60","author":"Hyysalo","year":"2014","journal-title":"J Hepatol"},{"key":"2025090711530252000_68.10.1884.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.01.002"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2018-317584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T18:53:17Z","timestamp":1757271197000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2018-317584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,19]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,9,6]]},"published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1136\/gutjnl-2018-317584"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2018-317584","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,19]]}}}